Results 111 to 120 of about 5,891 (192)

Quantitative Assessment of GFAP-Based Astrocyte Morphology in the Cuprizone Model: A Comparative Evaluation of Neurolucida^® 360 and SNT. [PDF]

Cells
Wenzel L, Heinig L, Wang D, Vankriekelsvenne E, Wigger N, Zimmermann A, Rößler J, Clarner T, Kipp M.   +8 more
europepmc   +1 more source

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes. [PDF]

Acta Neuropathol
Kaddatz H, Wenzel L, Pril E, Meien S, Harz V, Burkert L, Behrangi N, Zimmermann A, Frintrop L, Amor S, Kipp M, Heinig L.   +11 more
europepmc   +1 more source

Neuroprotective effects of glucotropaeolin as the major glucosinolate of cress seed on cuprizone-induced mouse model of multiple sclerosis. [PDF]

Biochem Biophys Rep
Bathaee M, Seyedabadi M, Shokati Sayyad M, Sheidaei S, Shahani S.   +4 more
europepmc   +1 more source

Detecting early brain susceptibility changes before demyelination in cuprizone mouse model using quantitative susceptibility mapping (QSM). [PDF]

Neuroimage
Han X, Chen J, Liu Z, Liu J, Lin M, Wang N.   +5 more
europepmc   +1 more source

Spatiotemporal APLNR Expression Dynamics During Oligodendroglial Remodeling of the Corpus Callosum in the Cuprizone Model. [PDF]

Int J Mol Sci
Gaydarski L, Petrova K, Stamenov N, Iliev A, Stanchev S, Rashev P, Pupaki D, Mourdjeva M, Kostadinova I, Landzhov B.   +9 more
europepmc   +1 more source

Label-free tracking of subcortical white matter degradation <i>in vivo</i> using third harmonic generation microscopy in a mouse model of multiple sclerosis. [PDF]

Biomed Opt Express
Chernavsky NE, Hong N, Trigiani LJ, Nishimura N, Schaffer CB.   +4 more
europepmc   +1 more source

Testing an inverse link between limbic alpha-synucleinopathy and myelin markers in mice and humans. [PDF]

NPJ Parkinsons Dis
Clark RN, Landes RE, Abbas M, Mistretta VG, Jhaveri JR, DeLoatch KA, Franks J, Chen J, Luk KC, Hu X, Leak RK.   +10 more
europepmc   +1 more source

Insights and challenges on animal models for progressive multiple sclerosis. [PDF]

J Neuroinflammation
Nalepa IF, Haahr NO, Bekiaris V, Jakobsen MR, Asuni AA, Benmamar-Badel A.   +5 more
europepmc   +1 more source

Autoradiographic assessment of SynVesT-1 revealed changes in non-displaceable binding with demyelination and remyelination: implications for SV2A PET analysis. [PDF]

EJNMMI Res
Panichnantakul P, Shaw RC, Burianova VK, McErlain H, Sutherland A, Williams AC, Waldman AD, Tavares AAS.   +7 more
europepmc   +1 more source

Pathological extracellular matrix changes in decellularized normal appearing gray matter and subpial multiple sclerosis lesions. [PDF]

iScience
de Jong JM, Wolters JC, Wijering MHC, de Vries J, Kooistra SM, Eggen BJL, Baron W.   +6 more
europepmc   +1 more source